Jenburkt Pharmaceuticals Ltd.
BSE: 524731 | Sector: Health care |
NSE: N.A. | ISIN Code: INE354A01013 |
BSE 00:00 | 10 Aug | 545.25 |
5.85 (1.08%) |
OPEN
539.40 |
HIGH
553.05 |
LOW
535.70 |
NSE 05:30 | 01 Jan | Jenburkt Pharmaceuticals Ltd |
OPEN | 539.40 |
PREVIOUS CLOSE | 539.40 |
VOLUME | 7067 |
52-Week high | 699.70 |
52-Week low | 452.00 |
P/E | 10.60 |
Mkt Cap.(Rs cr) | 250 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Jenburkt Pharmaceuticals Ltd. (JENBURKTPHARMA) - Total Assets
Total Assets
COMPANY | LATEST(Rs) | CHG(%) | Gross Block | Net Block | CWIP | Total Assets |
Sun Pharma.Inds. | 919.35 | 0.97 | 17194.98 | 9712.78 | 828.64 | 30678.37 |
Piramal Enterp. | 1820.75 | 1.68 | 1493.82 | 1417.12 | 3.46 | 29038.13 |
Cipla | 1038.20 | 0.87 | 6340.43 | 3391.04 | 213.84 | 22671.86 |
Dr Reddy's Labs | 4242.40 | 0.52 | 13349.10 | 6150.50 | 1200.30 | 20636.20 |
Lupin | 669.70 | 0.55 | 6705.14 | 3690.18 | 947.44 | 19439.28 |
Aurobindo Pharma | 564.25 | -0.70 | 5724.90 | 3585.83 | 225.15 | 19017.26 |
Glenmark Pharma. | 375.70 | 1.02 | 2848.56 | 1722.49 | 131.40 | 18627.19 |
Zydus Lifesci. | 364.65 | 1.12 | 7685.80 | 4335.90 | 384.00 | 16096.50 |
Divi's Lab. | 3945.65 | 0.18 | 5617.69 | 4320.97 | 469.93 | 11718.06 |
Alkem Lab | 2957.55 | -0.93 | 2826.98 | 1882.07 | 232.45 | 11301.35 |
Fortis Health. | 267.55 | -0.72 | 1173.15 | 770.29 | 6.33 | 10080.65 |
Torrent Pharma. | 1540.90 | -1.05 | 10002.35 | 6251.25 | 567.50 | 9910.76 |
Apollo Hospitals | 4519.05 | 2.04 | 7387.60 | 5120.70 | 23.90 | 8868.60 |
Biocon | 313.20 | -0.13 | 2277.10 | 870.20 | 284.90 | 8279.00 |
Gland Pharma | 2307.30 | -0.78 | 2081.32 | 1502.19 | 190.75 | 7164.70 |
Max Healthcare | 371.60 | -2.61 | 3079.39 | 2988.96 | 8.34 | 6439.88 |
Ipca Labs. | 991.85 | -2.00 | 3276.06 | 2084.78 | 289.04 | 6342.72 |
Alembic Pharma | 652.35 | -1.72 | 2098.10 | 1461.18 | 1927.63 | 5906.49 |
Dishman Carbogen | 114.75 | -6.52 | 2364.24 | 1509.65 | 121.20 | 5219.89 |
Laurus Labs | 558.70 | 1.43 | 3254.00 | 2186.23 | 755.03 | 5178.13 |
Quick Links for Jenburkt Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices